All CIRM Grants

Institution Researcher name Grant Type Grant Title Award Value
Keystone Symposia on Molecular and Cellular Biology Thale Jarvis Conference II Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells) $35,000
University of California, Irvine LESLIE Thompson Conference II HD-CARE INAUGURAL SYMPOSIUM $1,500
Children's Hospital of Los Angeles Mark Frey Therapeutic Translational Research Projects ASCENT- Advanced Stem Cell Enteric Neuropathy Therapy $7,077,352
University of California, Davis Joseph Anderson Therapeutic Translational Research Projects Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease $883,174
City of Hope, Beckman Research Institute Yanhong Shi Therapeutic Translational Research Projects Process development for establishing an iPSC-based therapeutic candidate for Canavan disease $7,377,384
Capricor, Inc Linda Marban Clinical Trial Stage Projects Allogeneic Cardiosphere-Derived Cells for Duchenne Muscular Dystrophy Cardiomyopathy $3,376,259
University of California, Los Angeles Lili Yang Therapeutic Translational Research Projects Stem Cell-Based iNKT Cell Therapy for Cancer $6,956,775
University of California, San Diego Lawrence Goldstein Therapeutic Translational Research Projects Human Embryonic Stem Cell-Derived Neural Stem Cell Transplants in Amyotrophic Lateral Sclerosis $1,790,000
University of California, Los Angeles Peter Butler Therapeutic Translational Research Projects Personalized Cell Therapy for Diabetes $1,494,896
Semma Therapeutics Felicia Pagliuca Therapeutic Translational Research Projects Personalized Cell Therapy for Diabetes $597,333
University of California, San Francisco Jennifer Puck Late Stage Preclinical Projects Ex Vivo Transduction of the Human Artemis (DCLRE1C) cDNA by Lentiviral Vector AProArt into CD34+ Hematopoietic Cells for Artemis (ART)-Deficient Severe Combined Immunodeficiency (SCID) $4,268,865
Mosaic Event Management, Inc. Ron Johnson Conference - Manage The 2016 Bridges And SPARK Annual Meetings 2016 CIRM Bridges & SPARK Meetings $205,388
Angiocrine Bioscience, Inc. Paul Finnegan Late Stage Preclinical Projects Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy $3,797,117
University of California, San Diego Catriona Jamieson Conference - The 2016 Alpha Stem Cell Clinic Annual Symposium UCSD Division of Regenerative Medicine and CIRM Alpha Clinics Network Symposium $37,778
California State University San Marcos Corporation Bianca Mothe Bridges CIRM Bridges to Stem Cell Research and Therapy Training Grant $2,936,474
Cedars-Sinai Medical Center Wafa Tawackoli SPARK Mentored High School Summer Research Program $296,628
San Diego State University Foundation Ralph Feuer Bridges Bridges to Stem Cell Research Internship Program $2,934,578
University of California, Davis Gerhard Bauer SPARK Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility $360,573
California State University, Channel Islands Nitika Parmar Bridges CIRM Graduate Student Training Grant for the Implementation of a Stem Cell Technology and Lab Management Program: Training in Stem Cell Sciences and Regenerative Medicine $2,925,187
University of California, San Francisco Katherine Nielsen SPARK Developing High School Students' Research Practices and Regenerative Medicine Knowledge through a Summer Intern Program $382,430
Cal State Univ, Fullerton Nilay Patel Bridges Bridges to Stem Cell Research, Therapy and Careers: A Talent Development Program for Training Diverse Undergraduates for Careers in Regenerative Medicine $2,854,530
Stanford University Paul Utz SPARK Stem Cell and Regenerative Medicine- Summer Research Internship $350,482
Cal State Univ, Long Beach Lisa Klig Bridges CIRM Stem Cell Biotechnology Training Program $2,919,901
California Institute of Technology Henry Lester SPARK CIRM Early Investigators High School Stem Cell Research Program $132,717
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo Trevor Cardinal Bridges Interdisciplinary Master of Science Program in Regenerative Medicine $2,556,199
Cal State Univ, Sacramento Lisa Hammersley Bridges Strengthening the Pipeline of Master's-level Scientific and Laboratory Personnel in Stem Cell Research $2,049,679
San Francisco State University Lily Chen Bridges CIRM Bridges 2.0: Training the Next Generation of Stem Cell Scientists $2,958,876
SJSU Research Foundation Tzvia Abramson Bridges SCILL- Stem Cell Internships in Laboratory-based Learning $3,086,302
Humboldt State University Sponsored Programs Foundation Jacob Varkey Bridges CIRM 2.0 Bridges Training Program $2,534,223
Pasadena City College Pamela Eversole-Cire Bridges Bridges to Stem Cell Research and Therapy at Pasadena City College $2,522,591
City College Of San Francisco Carin Zimmerman Bridges Stem Cell Training Enhancement Program with a focus on Translational Research $2,000,258
The University Corporation at California State University, Northridge Cindy Malone Bridges Stem Cell Scientist Training Program $2,732,149
Cal State Univ, San Bernadino Nicole Bournias-Vardiabasis Bridges Stem Cell Scholars- from Basic Research to Clinical Translation: training a diverse pool of students in the lab, engaging them in patient and healthcare activities, motivating them to educate their immediate community and enabling them for careers in ... $2,659,136
City of Hope, Beckman Research Institute Paul Salvaterra SPARK SPARK Award Program in Stem Cell Biology for California High School Students $241,080
UCSF Benioff Children’s Hospital Oakland Ellen Fung SPARK Leveraging Investment in hiGHschool Training: Summer Program to Accelerate Regenerative medicine Knowledge (LIGHT a SPARK) $226,519
University of California, San Diego John Ravits Conference II California ALS Research Summit 2016 $11,400
University of California, Los Angeles Donald Kohn Conference II Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
City of Hope, Beckman Research Institute Fouad Kandeel Conference II 2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium $10,000
Gordon Research Conferences Ophir Klein Conference II 2016 Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration $5,000
Stanford University Joseph Wu Conference II Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
ImmunoCellular Therapeutics Anthony Gringeri Clinical Trial Stage Projects A Phase III randomized double-blind, controlled study of ICT 107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy $5,391,016
University of California, Irvine Sidney Golub Conference II Human Research In Times of Controversy: From Stem Cells To Fetal Tissue $13,562
Sanford Consortium for Regenerative Medicine Edward Holmes Conference II Stem Cell Meeting on the Mesa $50,000
Alliance Forum Foundation George Hara Conference II 2015 World Alliance Forum in San Francisco (2015 WAFSF) "Regenerative Medicine: Let's Talk Business!" $10,000
Calibr Peter Schultz Late Stage Preclinical Projects Development of a Chondrogenic Drug Candidate Targeting Resident Mesenchymal Stem Cells for the Treatment of Osteoarthritis $1,667,832
University of California, Davis Mehrdad Abedi Clinical Trial Stage Projects Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients $8,414,265
University of California, Los Angeles Donald Kohn Clinical Trial Stage Projects A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease $7,083,364
Cedars-Sinai Medical Center Shaomei Wang Late Stage Preclinical Projects IND-enabling study of subretinal delivery of human neural progenitor cells for the treatment of retinitis pigmentosa $4,954,514
Caladrius Biosciences Robert Dillman Clinical Trial Stage Projects Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial. $3,000,000
Salk Institute for Biological Studies David Schubert Preclinical Development Awards Human Stem-Cell Based Development of a Potent Alzheimer’s Drug Candidate $1,664,885
University of California, Irvine Leslie Thompson Preclinical Development Awards A hNSC Development Candidate for Huntington’s Disease $4,951,623
Calibr Peter Schultz Preclinical Development Awards Development of a Chondrogenic Drug Candidate Targeting Cartilage-residing Mesenchymal Stem Cells for the Treatment of Osteoarthritis $2,306,703
University of California, Davis Diana Farmer Preclinical Development Awards Placental Stem Cells for the In Utero Treatment of Spina Bifida $2,182,146
University of California, Davis Roslyn Isseroff Preclinical Development Awards Scaffold for dermal regeneration containing pre-conditioned mesenchymal stem cells to heal chronic diabetic wounds $4,620,144
Scripps Health Darryl D'Lima Preclinical Development Awards Embryonic Stem Cell-Derived Chondroprogenitor Cells to Repair Osteochondral Defects $7,660,211
Stanford University Matthew Porteus Preclinical Development Awards Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1 $874,877
Vitalant Research Institute Shibani Pati Conference Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers $40,000
University of Southern California Qing Liu-Michael Conference USC/UCSF/UCLA Tri-Institutional Stem Cell Retreat $5,000
Ocular Research Symposia Foundation, Inc. Gerald Chader Conference SIGHT RESTORATION THROUGH STEM CELL THERAPY $20,000
Stanford University Joseph Wu Conference Cardiovascular Tissue Engineering Symposium $25,000
University of California, Davis Randi Hagerman Conference Pathways of Neurodevelopmental Disorders (C8) $29,939
Scripps Research Institute Jeanne Loring Tools and Technologies III User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery $1,728,390
University of California, Los Angeles Leif Havton Tools and Technologies III Development of a Relevant Pre-Clinical Animal Model as a Tool to Evaluate Human Stem Cell-Derived Replacement Therapies for Motor Neuron Injuries and Degenerative Diseases $1,308,711
University of California, Los Angeles James Dunn Tools and Technologies III Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $1,044,423
University of California, Davis J. Leach Tools and Technologies III Multi-modal technology for non-destructive characterization of bioengineered tissues $1,574,151
University of California, Davis Laura Marcu Tools and Technologies III Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs $1,834,350
Stanford University Fan Yang Tools and Technologies III Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival $1,434,235
Stanford University Sarah Heilshorn Tools and Technologies III Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System $1,347,767
University of California, Irvine Mathew Blurton-Jones Tools and Technologies III Optimizing the differentiation and expansion of microglial progenitors from human pluripotent stem cells for the study and treatment of neurological disease. $1,147,596
City of Hope, Beckman Research Institute Joseph Gold Tools and Technologies III Development of a scalable, practical, and transferable GMP-compliant suspension culture-based differentiation process for cardiomyocyte production from human embryonic stem cells. $891,518
Stanford University Irving Weissman Tools and Technologies III Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp... $1,271,952
University of Southern California Toshio Miki Tools and Technologies III Development of a clinical-grade extracorporeal liver support system using human induced pluripotent stem cell-derived hepatic cells $1,257,011
Stanford University James Dunn Tools and Technologies III Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $772,098
University of Southern California Paula Cannon Tools and Technologies III Site-specific gene editing in hematopoietic stem cells as an anti-HIV therapy $1,495,665
University of California, Los Angeles Hanna Mikkola Tools and Technologies III A suite of engineered human pluripotent stem cell lines to facilitate the generation of hematopoietic stem cells $1,382,400
University of Southern California Qilong Ying Tools and Technologies III Embryonic stem cell-based generation of rat models for assessing human cellular therapies $1,326,979
Stanford University Anthony Oro Tools and Technologies III A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability $1,391,125
University of California, San Francisco Andrew Leavitt Tools and Technologies III Small molecule tools and scale-up technologies to expand human umbilical cord blood stem and progenitor cells for clinical and research use $1,416,600
University of California, San Diego Shaochen Chen Tools and Technologies III Development of 3D Bioprinting Techniques using Human Embryonic Stem Cells Derived Cardiomyocytes for Cardiac Tissue Engineering $1,368,264
Stanford University Joseph Wu Tools and Technologies III Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts $1,689,744
University of California, Berkeley David Schaffer Tools and Technologies III Engineered Biomaterials for Scalable Manufacturing and High Viability Implantation of hPSC-Derived Cells to Treat Neurodegenerative Disease $1,239,276
University of California, Los Angeles Carla Koehler Tools and Technologies III A small molecule tool for reducing the malignant potential in reprogramming human iPSCs and ESCs $1,283,900
University of California, San Diego Shyni Varghese Tools and Technologies III Technologies to improve in vivo function of transplanted stem cells $1,373,683
Gordon Research Conferences Leonard Zon Conference 2015 Gordon Research Conference: Stem Cells & Cancer $20,000
City of Hope, Beckman Research Institute Fouad Kandeel Conference 15th Annual Rachmiel Levine Diabetes and Obesity Symposium $20,000
Gladstone Institutes, J. David Steven Finkbeiner Conference THE 5TH ANNUAL CALIFORNIA ALS PAC10 AND RESEARCH NETWORK MEETING $9,529
University of California, San Diego Catriona Jamieson Alpha Stem Cell Clinics Alpha Stem Cell Clinic for the Development of Regenerative Therapies $8,679,137
University of California, Los Angeles John Adams Alpha Stem Cell Clinics UCLA-UCI Alpha Stem Cell Clinic (ASCC) Consortium $8,680,000
City of Hope, Beckman Research Institute John Zaia Alpha Stem Cell Clinics The Innovation-Alpha Clinic for Cellular Therapies (I-ACT) – A Program for the Development and Delivery of Innovative Cell-based Treatments and Cures for Life-threatening Diseases. $8,456,000
University of California, Davis Alice Tarantal Conference 13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $10,000
ViaCyte, Inc. Howard Foyt Accelerated Development Pathway I Clinical Development of a Cell Therapy for Diabetes $8,783,852
Sanford Consortium for Regenerative Medicine Edward Holmes Conference Stem Cell Meeting on the Mesa $40,000
University of California, San Francisco Susan Fisher Conference The Stem Cell Niche in Development and Disease $5,000
University of California, San Francisco Diana Laird Conference The 2014 Santa Cruz Developmental Biology Meeting $3,000
Lineage Cell Therapeutics Inc. Francois Binette Strategic Partnership III Track A A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury $14,323,318
City of Hope, Beckman Research Institute John Zaia Strategic Partnership III Track A A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Sub... $5,583,438
University of California, Berkeley Xavier Darzacq Research Leadership Single Molecule Biophysics and Biology of Cellular Identity $4,175,924
Gladstone Institutes, J. David Todd McDevitt Research Leadership Engineering microscale tissue constructs from human pluripotent stem cells $5,849,100
University of California, Los Angeles John Chute Research Leadership Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors $4,645,297
University of California, Irvine Michelle Khine Conference UC Systemwide Bioengineering Symposium $7,525

Pages

Icon for XLSX export